Metabolix Inc was incorporated in Massachusetts in June 1992 under the name Metabolix, Inc. In September 1998, it reincorporated in Delaware. The Company is an innovation-driven bioscience company focused on delivering sustainable solutions to the plastics and chemicals industries. It is engaged in products and markets development of a biopolymer platform, based on technology developed by the Company and early commercialization efforts conducted through the Telles joint venture with ADM. The Company has its operations in U.S. and Canada. It has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and has assembled these capabilities in a way that has allowed the Company to integrate its biotechnology research with real world chemical engineering and industrial practice. It has created an intellectual property portfolio to protect its innovations and, together with its technology, to serve as a valuable foundation for future industry collaborations. It has focused on a family of biopolymers found in nature called polyhydroxyalkanoates "PHA", which occur naturally in living organisms and are chemically similar to polyesters. It has demonstrated the production of PHAs at industrial scale to produce PHA biopolymers and PHA precursors to biobased industrial chemicals. It has also demonstrated the production of polyhydroxybutyrate, a subclass of PHAs, in agriculturally non-food crops. Polymers are found in nature in a range of organisms including microbes, plants and animals. The Company competes with Dow Chemical, DuPont, BASF, Ineos, LyondellBasell, SABIC, Mitsubishi Chemical, DuPont, DSM, Arkema and Braskem. The Company is subject to foreign and domestic government regulations, and compliance or failure to comply with these regulations could harm its business.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.